Senior insider sale
Chief Medical Officer at REATA PHARMACEUTICALS INC — senior position signals high conviction
$889.5K
8.38K shares
MEYER COLIN JOHN plans to sell 8.38K shares of REATA PHARMACEUTICALS INC valued at approximately $889.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/6/2023 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 388.00 | — |
6/30/2023 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 1.76K | — |
| Total | 2.14K | ||
Completed
Units to sell
625.00
Market value
$50.6K
Units to sell
5.61K
Market value
$476.5K
Planned — Approximate Date
Units to sell
2.14K
Market value
$362.5K
Units
8.38K
Value
$889.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/16/2023 | 625.00 | $50.6K | — | Completed |
5/15/2023 | 5.61K | $476.5K | — | Completed |
| Planned — Approximate Date | ||||
8/15/2023 | 2.14K | $362.5K | NASDAQ | Planned |
| Total | 8.38K | $889.5K | ||